Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President & CEO, Director
-
Stock Symbol
-
MBX on Nasdaq
P. Kent Hawryluk - trading volume in the past year for MBX Biosciences, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
481K |
$5.15M |
$10.69 |
Feb 3, 2025 |
Direct |
|
|
| Common Stock |
448K |
$4.79M |
$10.69 |
Feb 4, 2025 |
By Trust |
|
|
| Stock Option (Right to Buy) |
243K |
|
|
Feb 3, 2025 |
Direct |
Common Stock |
|
| Series A Convertible Preferred Stock |
0 |
|
|
Sep 16, 2024 |
By Trust |
Common Stock |
|
| Series A Convertible Preferred Stock |
0 |
|
|
Sep 16, 2024 |
Direct |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
Sep 16, 2024 |
By Trust |
Common Stock |
|
| Series B Convertible Preferred Stock |
0 |
|
|
Sep 16, 2024 |
Direct |
Common Stock |
|
| Series C Convertible Preferred Stock |
0 |
|
|
Sep 16, 2024 |
By Trust |
Common Stock |
|
Transactions reported by P. Kent Hawryluk for MBX Biosciences, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.